Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Li, Banban"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway
    Autorzy:
    Sun, JikuiAff1, Aff2, Aff4, Aff5
    Li, Banban
    Jia, ZhifanAff4, Aff5, Aff6, Aff7
    Zhang, AnlingAff4, Aff5, Aff6, Aff7
    Wang, GuangxiuAff4, Aff5, Aff6, Aff7
    Chen, ZhijuanAff4, Aff5, Aff6, Aff7
    Shang, ZhendeAff1, Aff2
    Zhang, Chaocai
    Cui, Jian
    Yang, WeidongAff4, Aff5, Aff6, Aff7
    Pokaż więcej
    Źródło:
    Journal of Neuro-Oncology. 140(1):15-26
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    [Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them].
    Autorzy:
    Shi Y; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    Li P; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    Li B; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    Zhang F; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    Huang S; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    Shen S; Department of Tumor Radiotherapy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    Li X; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    Pokaż więcej
    Źródło:
    Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2019 May 20; Vol. 22 (5), pp. 299-305.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Mutation*
    Carcinoma, Non-Small-Cell Lung/*drug therapy
    Carcinoma, Non-Small-Cell Lung/*genetics
    Lung Neoplasms/*drug therapy
    Lung Neoplasms/*genetics
    Protein Kinase Inhibitors/*pharmacology
    Disease-Free Survival ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Exons/genetics ; Female ; Humans ; Male ; Middle Aged ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Treatment Outcome
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    [Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung 
Adenocarcinoma].
    Autorzy:
    Li P; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
    Li B; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
    Shi Y; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
    Zhang F; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
    Shen S; Department of Tumor Radiotherapy, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
    Li X; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
    Pokaż więcej
    Źródło:
    Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2019 Mar 20; Vol. 22 (3), pp. 137-142.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Adenocarcinoma of Lung/*drug therapy
    Adenocarcinoma of Lung/*genetics
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Genes, erbB-2/*genetics
    Pemetrexed/*therapeutic use
    Platinum/*therapeutic use
    Adenocarcinoma of Lung/pathology ; Aged ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Retrospective Studies ; Treatment Outcome
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies